Candace Fuchs

Candace Fuchs is leading Clinical Operations and Project Management at AI Therapeutics. Candace began her career as a cancer biologist at Bayer Pharmaceuticals and leveraged her experience to support the development of Sorafenib. At Pfizer, Candace had responsibilities in clinical operations, supporting new drug applications for Sutent and Vizimpro, as well as translational research.